Literature DB >> 33308034

Inhibition analysis of aflatoxin by in silico targeting the thioesterase domain of polyketide synthase enzyme in Aspergillus ssp.

Mai M Labib1, M K Amin2, A M Alzohairy2, M M A Elashtokhy2, O Samir3, S E Hassanein1,4.   

Abstract

The spread of fungal growth causes enormous economic, agricultural, and health problems for humans, such as Aspergillus sp., which produce aflatoxins. Thus, the inhibition of aflatoxin production became a precious target. In this research, the thioesterase (TE) domain from Polyketide synthase enzyme was selected to employ the in silico docking, using AutoDock Vina, against 623 natural compounds from the South African natural compound database (SANCDB), to identify potential inhibitors that can selectively inhibit thioesterase domain. The top ten inhibitors components were pinocembrin, typhaphthalide, p-coumaroylputrescine, dilemmaone A, 9-angelylplatynecine, 2,4,6-octatrienal, 4,8-dichloro-3,7-dimethyl-, (2e,4z,6e)-, lilacinobiose, 1,3,7-octatriene, 5,6-dichloro-2-(dichloromethyl)-6-methyl-, [r*,s*-(e)]-(-)- (9ci), lilacinobiose, 1,3,7-octatriene, 5,6-dichloro-2-(dichloromethyl)-6-methyl-, [r*,s*-(e)]-(-)- (9ci), 1,3,7-octatriene, 1,5,6-trichloro-2-(dichloromethyl)-6-methyl-, [r*,s*-(z,e)] and 9-angelylhastanecine and that depending on the lowest binding energy, the best chemical interactions and the best drug-likeness. The results of those components gave successful inhibition with the thioesterase domain. So, they can be used for inhibition and controlling aflatoxin contamination of agriculture crop yields, specially, pinocembrin which gave promising results.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  Human challenges; aflatoxin; bioinformatics tools; in silico docking; thioesterase domain

Mesh:

Substances:

Year:  2020        PMID: 33308034     DOI: 10.1080/07391102.2020.1856186

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102            Impact factor:   5.235


  4 in total

Review 1.  Artificial intelligence to deep learning: machine intelligence approach for drug discovery.

Authors:  Rohan Gupta; Devesh Srivastava; Mehar Sahu; Swati Tiwari; Rashmi K Ambasta; Pravir Kumar
Journal:  Mol Divers       Date:  2021-04-12       Impact factor: 3.364

2.  Repurposing the antibacterial drugs for inhibition of SARS-CoV2-PLpro using molecular docking, MD simulation and binding energy calculation.

Authors:  Rohit Patel; Jignesh Prajapati; Priyashi Rao; Rakesh M Rawal; Meenu Saraf; Dweipayan Goswami
Journal:  Mol Divers       Date:  2021-09-30       Impact factor: 3.364

3.  First structure-activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery.

Authors:  Sk Abdul Amin; Suvankar Banerjee; Samayaditya Singh; Insaf Ahmed Qureshi; Shovanlal Gayen; Tarun Jha
Journal:  Mol Divers       Date:  2021-01-05       Impact factor: 3.364

4.  Investigation on electronic structure, vibrational spectra, NBO analysis, and molecular docking studies of aflatoxins and selected emerging mycotoxins against wild-type androgen receptor.

Authors:  John A Agwupuye; Peter A Neji; Hitler Louis; Joseph O Odey; Tomsmith O Unimuke; Emmanuel A Bisiong; Ededet A Eno; Patrick M Utsu; Tabe N Ntui
Journal:  Heliyon       Date:  2021-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.